We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Hospital Infections Prevalent in the United States

By HospiMedica staff writers
Posted on 09 Jul 2007
A new study reports that as many as 1.2 million hospital patients in the United States are infected with methicillin-resistant Staphylococcus aureus (MRSA) infections annually, with up to 120,000 patients of them dying.

The study, authored by Dr. More...
William Jarvis, former acting director of the hospital infections program at the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) and currently at the Association for Professionals in Infection Control & Epidemiology (APIC, Washington, DC, USA), is based on surveys sent during 2006 to 10,000 infection-control practitioners, including doctors and nurses in hospitals, nursing homes, and rehabilitation facilities. Participants were asked to select one day between October 1, 2005, and November 10, 2005, and report all known MRSA cases in their institutions. More than 1,200 hospitals and 100 nursing homes and rehabilitation facilities responded, supplying data about patients with MRSA infections.

The findings showed that 34 of 1,000 patients in the survey had active MRSA infections and that 12 were colonized with the bacteria, for a total MRSA prevalence rate of 46 per 1,000 patients. Applying the prevalence rates in the new study, the data suggest that 1.2 million hospital patients are afflicted with MRSA each year and that an additional 423,000 patients are colonized with the superbacteria.

"Everything we're finding is telling us the same thing: MRSA is an enormous problem in health-care facilities, more needs to be done to prevent it, and hospitals need to make infection control more of a priority,” said Dr. John Jernigan, a medical epidemiologist at the CDC, and the agency's lead expert on MRSA.

People colonized with MRSA typically carry it in their nose without being symptomatic. The major risk of passing the super-bacteria to others unknowingly by wiping their nose and then touching a table that a doctor or nurse later touches, since MRSA can live on surfaces for days or even weeks.


Related Links:
Centers for Disease Control and Prevention
Association for Professionals in Infection Control & Epidemiology

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.